Mengyuan Fang Selected Research

Antioxidants

10/2023

Novel pterostilbene derivatives ameliorate heart failure by reducing oxidative stress and inflammation through regulating Nrf2/NF-κB signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mengyuan Fang Research Topics

Disease

5	Inflammation (Inflammations) 12/2023 - 08/2021
2	Neoplasms (Cancer) 10/2023 - 01/2023
2	Heart Failure 10/2023 - 12/2022
2	Sepsis (Septicemia) 12/2021 - 08/2021
1	Atherosclerosis 12/2023
1	Vascular Calcification 12/2023
1	Macular Degeneration (Age-Related Maculopathy) 01/2023
1	Pathologic Processes 07/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2021
1	Macular Edema 10/2019

Drug/Important Bio-Agent (IBA)

3	pterostilbeneIBA 12/2023 - 08/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 12/2022
1	SaltsIBA 12/2023
1	CalciumIBA 12/2023
1	pyrazoleIBA 12/2023
1	LipidsIBA 12/2023
1	KetonesIBA 12/2023
1	ResveratrolIBA 10/2023
1	AntioxidantsIBA 10/2023
1	CytokinesIBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	StilbenesIBA 12/2022
1	NF-kappa B (NF-kB)IBA 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022
1	ThiazolesIBA 12/2021
1	indacrinoneIBA 08/2021
1	SolutionsIBA 08/2021
1	asiatic acidIBA 07/2021
1	TriterpenesIBA 07/2021
1	Fluorescein (Funduscein)FDA LinkGeneric 10/2019
1	Retinaldehyde (Retinal)IBA 10/2019

Therapy/Procedure

1	Therapeutics 01/2023